US$ 26.18
hyperthyroidism and glp 1 10 Surprising Facts About GLP-1/GIP Medications in Hypothyroid Patients Tirzepatide and Graves Disease: Safety
Description
doi: 10.1016/j.celrep.2021.109526 [DOI] [PubMed] [Google Scholar] 42.Cusi K

Newer medications, like tirzepatide, have a dual action, targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

This highlights GLP-1 Treatments, Semaglutide or Tirzepatide's potential as a powerful ally in the battle against obesity
Additional larger prospective studies are needed to further assess the mechanism of action of these drugs on the kidney and, hence, their effect on kidney stones

Universidade do Porto (Portugal)
